CEO of Zoetis Inc (ZTS, Financial) Juan Ramon Alaix sold 312,109 shares of ZTS on 02/28/2019 at an average price of $94.06 a share. The total sale was $29.4 million.
Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. Zoetis Inc has a market cap of $45.84 billion; its shares were traded at around $95.75 with a P/E ratio of 32.67 and P/S ratio of 8.00. The dividend yield of Zoetis Inc stocks is 0.58%. Zoetis Inc had annual average EBITDA growth of 19.80% over the past five years.
CEO Recent Trades:
- CEO Juan Ramon Alaix sold 312,109 shares of ZTS stock on 02/28/2019 at the average price of $94.06. The price of the stock has increased by 1.8% since.
Directors and Officers Recent Trades:
- Executive Vice President Clinton A. Jr. Lewis sold 6,125 shares of ZTS stock on 02/14/2019 at the average price of $91.96. The price of the stock has increased by 4.12% since.
- Executive Vice President Kristin C Peck sold 11,500 shares of ZTS stock on 02/12/2019 at the average price of $86.79. The price of the stock has increased by 10.32% since.
For the complete insider trading history of ZTS, click here
.
